Mersana Therapeutics
Price & Volume
Stats
See more52W Range | $5.21-$70.75 |
Market Cap | $47.1M |
Shares Short | 426,625 |
Financials
See moreRevenue (12 Mos) | $34.7M |
Revenue Growth (YoY) | 33.3% |
Gross Profit (12 Mos) | -$36.8M |
Diluted EPS | -$14.79 |
News
See moreYahoo Finance • 2 months ago
Mersana targets reporting initial Emi-Le expansion data in H2 2025 while achieving $15M GSK milestone
Yahoo Finance • 2 months ago
Form 8K Mersana Therapeutics Inc For: 13 August
Yahoo Finance • 2 months ago
Mersana Therapeutics Q2 2025 Earnings Preview
Yahoo Finance • 2 months ago
Mersana Therapeutics to Host Second Quarter 2025 Conference Call on August 13, 2025
About
CEO | Dr. Martin H. Huber M.D. |
CFO | Mr. Brian C. DeSchuytner |
Address | 840 Memorial Drive, Cambridge, MA, United States, 02139 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 102 |
